AI assistant
Sending…
Skye Bioscience, Inc. — Director's Dealing 2015
Apr 10, 2015
34097_dirs_2015-04-10_ba74da80-17cb-44eb-9e20-7e825d59d4c0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Nemus Bioscience, Inc. (NMUS)
CIK: 0001516551
Period of Report: 2015-04-08
Reporting Person: Ladin Brian D (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-04-08 | Common Stock | S | 23000 | $4.691 | Disposed | 276728 | Indirect |
| 2015-04-08 | Common Stock | S | 15800 | $4.79 | Disposed | 260928 | Indirect |
| 2015-04-10 | Common Stock | S | 11830 | $4.929 | Disposed | 249098 | Indirect |
Footnotes
F1: Represents shares of common stock directly beneficially owned by BRL TX-Family LP.
More from Skye Bioscience, Inc.
Declaration of Voting Results & Voting Rights Announcements
2026
May 29
Delisting Announcement
2026
May 15
Annual Report
2026
Apr 16
Proxy Solicitation & Information Statement
2026
Apr 16
Board/Management Information
2026
Apr 3
Delisting Announcement
2026
Mar 19
Board/Management Information
2026
Feb 20
Director's Dealing
2026
Feb 10
Director's Dealing
2026
Feb 10
Director's Dealing
2026
Feb 10